Sionna Therapeutics, Inc.

NASDAQ:SION

Biotechnology

Healthcare
$2.97 +1.85%

+$0.68 today

Market cap
$134.35M
Beta
1.29
P/E (TTM)
-19.7
EPS (TTM)
-$1.90
52W Low $13.81High $48.45

Volume 0.65M

Average 0.39M

Balance Sheet

Inspect the capital base behind the business.

Assets

$325.95M

FY 2025 · Annual

+75.5% YoY

Liabilities

$19.12M

FY 2025 · Annual

-94.5% YoY

Equity

$306.83M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents54.84M38.52M37.79M58.45M
Short-term Investments27.77M0109.75M177.43M
Net Receivables0000
Inventory0000
Other Current Assets1.22M686K3.46M5.54M
Total Current Assets83.83M39.21M150.99M241.42M
Property, Plant & Equipment (Net)2.57M11.73M10.3M9.15M
Goodwill0000
Intangible Assets0000
Long-term Investments0962K20.51M74.42M
Tax Assets0000
Other Non-current Assets962K44K3.96M963K
Total Non-current Assets3.54M12.74M34.76M84.53M
Total Assets87.37M51.95M185.75M325.95M
Account Payables557K719K1.19M769K
Short-term Debt0000
Tax Payables0000
Deferred Revenue0000
Other Current Liabilities1.95M3.11M2.97M4.75M
Total Current Liabilities8.25M8.04M10.42M11.71M
Long-term Debt0000
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities149.04M149.04M330.37M0
Total Non-current Liabilities149.04M158.79M339.05M7.41M
Total Liabilities157.29M166.83M349.47M19.12M
Common Stock2K2K5K45K
Retained Earnings(72.14M)(119.4M)(181.09M)(256.35M)
Accumulated OCI(16K)0368K540K
Other Stockholders Equity(149.04M)(149.04M)(330.37M)0
Minority Interest0000
Total Equity(69.92M)(114.88M)(163.71M)306.83M
Total Debt010.48M9.75M8.68M
Net Debt(54.84M)(28.04M)(28.04M)(49.77M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$63.3M
Short-term Investments$152.8M
Other Current$4.8M
Total Current Assets$221.0M
PP&E (Net)$8.8M
Long-term Investments$73.8M
Other Non-current$1.5M
Total Non-current Assets$84.1M
Total Assets$305.0M

Analysis

Selected assets total $305.0M for Latest. The largest visible component is Short-term Investments at $152.8M, about 50.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13GSC 13G filingNov 9, 2026
SC 13D/ASC 13D/A filingSep 21, 2026
4Statement of changes in beneficial ownershipSep 21, 2026

How much cash does SION have?

Sionna Therapeutics, Inc. (SION) reported $58.45M in cash and equivalents in fiscal 2025.

How much debt does SION carry?

Sionna Therapeutics, Inc. (SION) reported $8.68M of total debt, with net debt of -$49.77M.